These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12658802)

  • 1. Apoptosis of leukemia cells induced by CD34+ cells transferred exogenous Fas ligand.
    Xiao J; Zou P; Liu Z; Hu Z; Liu L
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(3):197-9. PubMed ID: 12658802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the Fas/FasL pathway during chemotherapeutic drug-induced apoptosis of leukaemeic cells.
    Zou P; Liu Z; Xiao J
    J Tongji Med Univ; 2001; 21(3):212-4. PubMed ID: 12539579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apoptosis of the allo-antigen specific T cells induced by CD34(+) cells transfected with exogenous gene FasL].
    Liu ZW; Xiao J; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):56-60. PubMed ID: 12513839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.
    Lewis NR; Pallis M; Russell NH
    Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective depletion of the allo-antigen specific T cells by Fas/FasL pathway by cytokine IFN-gamma and IL-2.
    Xiao J; Zou P; Liu Z; Liu L; Hu Z
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):344-7. PubMed ID: 15015631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis.
    Josefsen D; Myklebust JH; Lynch DH; Stokke T; Blomhoff HK; Smeland EB
    Exp Hematol; 1999 Sep; 27(9):1451-9. PubMed ID: 10480436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
    Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
    Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
    Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
    J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of Fas/FasL-mediated apoptosis by luteolin through enhancement of histone H3 acetylation and c-Jun activation in HL-60 leukemia cells.
    Wang SW; Chen YR; Chow JM; Chien MH; Yang SF; Wen YC; Lee WJ; Tseng TH
    Mol Carcinog; 2018 Jul; 57(7):866-877. PubMed ID: 29566277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synergistic increase of apoptosis utilizing Fas antigen expression induced by low doses of anticancer drug.
    Akiyama H; Ino T; Tokunaga E; Katsuda I; Ezaki K
    Rinsho Byori; 2003 Aug; 51(8):733-9. PubMed ID: 13677932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to exogenous DNA can modify the sensitivity of the Fas apoptotic pathway.
    de Carvalho Bittencourt M; Saas P; Fresnay S; Yerly-Motta V; Ferrand C; Perruche S; Duperrier A; Hervé P; Tiberghien P; Chalmers DE
    J Gene Med; 2002; 4(1):14-24. PubMed ID: 11828383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfection of tubule cells with Fas ligand causes leukocyte apoptosis.
    Wang Y; Yi S; Tay YC; Feng X; Wang Y; Kairaitis L; Harris DC
    Kidney Int; 2002 Apr; 61(4):1303-11. PubMed ID: 11918737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system.
    McGahon AJ; Costa Pereira AP; Daly L; Cotter TG
    Br J Haematol; 1998 Jun; 101(3):539-47. PubMed ID: 9633899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling.
    Margalit KA; Cowan RG; Harman RM; Quirk SM
    Reproduction; 2005 Nov; 130(5):751-8. PubMed ID: 16264104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis.
    Xerri L; Devilard E; Hassoun J; Haddad P; Birg F
    Leukemia; 1997 Nov; 11(11):1868-77. PubMed ID: 9369420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy.
    Sata M; Suhara T; Walsh K
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):309-16. PubMed ID: 10669625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Fas IgM monoclonal antibody enhances apoptosis induced by low-dose cytosine arabinoside.
    Nakamura S; Takeshima M; Nakamura Y; Ohtake S; Matsuda T
    Anticancer Res; 1999; 19(1A):197-204. PubMed ID: 10226543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action.
    Belanger AJ; Scaria A; Lu H; Sullivan JA; Cheng SH; Gregory RJ; Jiang C
    Cardiovasc Res; 2001 Sep; 51(4):749-61. PubMed ID: 11530108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
    Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
    Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.